Page last updated: 2024-08-24

imiquimod and luteolin

imiquimod has been researched along with luteolin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Albanesi, C; Avigliano, L; Cavani, A; Madonna, S; Mauriello, A; Melino, G; Palombo, R; Savini, I; Terrinoni, A	1
Du, J; Du, Z; Hu, J; Hu, M; Liu, Q; Xiang, Z; Zang, X; Zhang, L; Zhou, W	1

Other Studies

2 other study(ies) available for imiquimod and luteolin

Article	Year
Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell death & disease, 2016, 08-18, Volume: 7, Issue:8 Topics: Acanthosis Nigricans; Aminoquinolines; Animals; Cell Differentiation; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Glucosides; Humans; Imiquimod; Immunohistochemistry; Inflammation; Interleukin-22; Interleukins; Keratinocytes; Lipids; Luteolin; Mice, Inbred C57BL; Oxidation-Reduction; Phenotype; Protein Transport; Psoriasis; Signal Transduction; STAT3 Transcription Factor	2016
Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via suppression of inflammation response. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131 Topics: Animals; Anti-Inflammatory Agents; Cytokines; Female; Imiquimod; Luteolin; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Psoriasis; RAW 264.7 Cells	2020

Article

Year

Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.

Cell death & disease, 2016, 08-18, Volume: 7, Issue:8

Topics: Acanthosis Nigricans; Aminoquinolines; Animals; Cell Differentiation; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Glucosides; Humans; Imiquimod; Immunohistochemistry; Inflammation; Interleukin-22; Interleukins; Keratinocytes; Lipids; Luteolin; Mice, Inbred C57BL; Oxidation-Reduction; Phenotype; Protein Transport; Psoriasis; Signal Transduction; STAT3 Transcription Factor

2016

Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via suppression of inflammation response.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131

Topics: Animals; Anti-Inflammatory Agents; Cytokines; Female; Imiquimod; Luteolin; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Psoriasis; RAW 264.7 Cells

2020